The Increasingly Human and Profitable Monoclonal Antibody Market

Trends in Biotechnology

Volumn 37, Issue 1, 2019, Pages 9-16

  Grilo, António L ^a   Mantalaris, A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

biosimilars; market analysis; monoclonal antibody

Indexed keywords

MOLECULES; MONOCLONAL ANTIBODIES;

BIOSIMILARS; EMERGING MARKETS; MARKET ANALYSIS; MONOCLONAL ANTIBODIES (MAB); THERAPEUTIC APPLICATION;

COMMERCE;

BIOSIMILAR AGENT; MONOCLONAL ANTIBODY; IMMUNOLOGIC FACTOR;

ANTIBODY STRUCTURE; DRUG MANUFACTURE; DRUG MARKETING; HUMAN; PRIORITY JOURNAL; PROFIT; SHORT SURVEY; GLOBAL HEALTH; IMMUNOTHERAPY; ISOLATION AND PURIFICATION; PROCEDURES; TRENDS;

ANTIBODIES, MONOCLONAL; GLOBAL HEALTH; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTHERAPY;

EID: 85048855123     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2018.05.014     Document Type: Short Survey

References (10)

1. Walsh, G., Biopharmaceutical benchmarks 2014. Nat. Biotechnol. 32 (2014), 992–1000.
2. Aggarwal, S., What's fueling the biotech engine – 2012 to 2013. Nat. Biotechnol. 32 (2014), 32–39.
3. Ecker, D.M., et al. The therapeutic monoclonal antibody market. MAbs 7 (2015), 9–14.
4. Wolf, E., et al. BiTEs: bispecific antibody constructs with unique anti-tumor activity. Drug Discov. Today 10 (2005), 1237–1244.
5. Lynch, D.H., Yang, X.-D., Therapeutic potential of ABX-EGF: a fully human anti-epidermal growth factor receptor monoclonal antibody for cancer treatment. Semin. Oncol. 29 (2002), 47–50.
6. Nelson, A.L., et al. Development trends for human monoclonal antibody therapeutics. Nat. Rev. Drug Discov. 9 (2010), 767–774.
7. Higel, F., et al. N-Glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins. Eur. J. Pharm. Biopharm. 100 (2016), 94–100.
8. Gautam, A., Market watch: strategies for biosimilars in emerging markets. Nat. Rev. Drug Discov., 16, 2017 520–521/supplementary material.
9. Wei, L., Ng, M., Overview of the domestic and international monoclonal antibody market. China Biotechnol. 37 (2017), 106–114.
10. Ellis, S., Braced for the biotech boom. Naturejobs Career Guide: China, 2018, Springer Nature.